by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Leading Edge Health Inc. Warning Letter Details

Warning Letter

Leading Edge Health Inc.

300-1095 McKenzie Avenue Victoria BC V8P 2L5 Canada

Issue DateJune 17, 2026

FEI NumberN/A

Violations1

CountryCanada

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Unapproved New Drugs/Misbranded

Leading Edge Health Inc. FDA Warning Letter, June 17, 2026